Publication | Open Access

Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism

Covalent InhibitorsDrug TargetBiochemistryMedicineMultiple Serine HydrolasesM. Tuberculosis GrowthAnti-cancer AgentDrug DevelopmentPharmacologyInhibitory ActivityDrug Discovery